The global progressive pulmonary fibrosis (PPF) treatment market is projected to be valued at USD 4,044.6 Million in 2025 and is expected to reach USD 8,182.4 Million by 2035, registering a CAGR of 7.

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Lung macrophages play a pivotal role in diseases like idiopathic pulmonary fibrosis. Two types of macrophages—the white blood ...

Results come after positive results from a trial among people with idiopathic pulmomary disease.

Panelists discuss recent trial data demonstrating that a novel agent not only slows lung function decline but also delays ...

Panelists discuss how emerging, better-tolerated oral therapies for idiopathic pulmonary fibrosis (IPF) and progressive ...

Pliant Therapeutics has terminated its idiopathic pulmonary fibrosis (IPF) program after digging into the increased rate of ...

The University of Texas at Tyler was awarded a $219,000 grant to help fund a professor’s pulmonary fibrosis treatment project ...

The website you are visiting is protected and accelerated by Imperva. Your computer may have been infected by malware and ...

Yoga can be a valuable complement to pulmonary therapy for chronic respiratory diseases, such as COPD and asthma. By ...

He chased eclipses for five decades, wrote several books about them and worked with NASA to make data accessible to ...